Gonococcal infection of lower genitourinary tract, unspecified
ICD-10 A54.0 is a billable code used to indicate a diagnosis of gonococcal infection of lower genitourinary tract, unspecified.
Gonococcal infection of the lower genitourinary tract is a sexually transmitted infection caused by the bacterium Neisseria gonorrhoeae. This infection primarily affects the urethra in men and the cervix in women, but it can also involve the rectum and throat. Symptoms may include dysuria, increased urinary frequency, purulent discharge, and pelvic pain. In some cases, the infection can be asymptomatic, particularly in women, which can lead to complications such as pelvic inflammatory disease (PID) if left untreated. Diagnosis is typically made through nucleic acid amplification tests (NAATs) or culture methods. Treatment usually involves a dual therapy regimen of antibiotics, commonly ceftriaxone and azithromycin, to effectively eradicate the infection and prevent the development of antibiotic resistance. Contact tracing is crucial for managing gonococcal infections, as it helps identify and treat sexual partners to prevent reinfection and further transmission.
Detailed patient history, including sexual history and previous STIs.
Diagnosis and management of gonococcal infections, treatment of co-infections.
Documentation of antibiotic resistance patterns and follow-up testing.
Clinical findings related to urinary symptoms and any complications.
Management of urethritis and complications such as epididymitis.
Need for clear documentation of diagnostic tests and treatment plans.
Used for confirming gonococcal infection in symptomatic patients.
Document the reason for testing and the patient's symptoms.
Infectious disease specialists may require additional details on treatment response.
Common symptoms include dysuria, purulent discharge, and pelvic pain. However, many individuals may be asymptomatic.
Treatment typically involves a dual therapy regimen of ceftriaxone and azithromycin to effectively treat the infection.
Contact tracing helps identify and treat sexual partners, reducing the risk of reinfection and further transmission of the disease.
